サウスカロライナにおける多発性骨髄腫の臨床試験
サウスカロライナ内の拠点で、多発性骨髄腫に関する9件の研究が参加者を募集しています。
サウスカロライナ内の都市
公式研究テキスト（英語）
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Bon Secours Saint Francis Cancer Center, Greenville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07518186A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- MUSC-Hollings Cancer Center, Charleston
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05552222TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- SC Cancer Specialists at St. Joseph's/Candler Bluffton, Bluffton
- St. Joseph's/Candler Smith, Bluffton
- Summit Cancer Care at St. Josph's/Candler Bluffton, Bluffton
- 他1件
被験者募集中第2相
12歳以上 · 全性別 · 2026/09/22更新 · NCT02693535Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Ralph H Johnson VA Medical Center, Charleston
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/19更新 · NCT04566328A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
- Medical University of South Carolina (MUSC) - Hollings Cancer Center, Charleston
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT05651932Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Prisma Health Cancer Institute - Spartanburg, Boiling Springs
- Prisma Health Cancer Institute - Easley, Easley
- Prisma Health Cancer Institute - Butternut, Greenville
- 他4件
被験者募集中第3相
全年齢 · 全性別 · 2026/06/10更新 · NCT05561387Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
- Medical University of South Carolina (MUSC), Charleston
- Gibbs Cancer Center, Spartanburg
被験者募集中第3相
18歳以上 · 全性別 · 2026/06/04更新 · NCT05243797A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Medical University of South Carolina, Charleston
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/03/24更新 · NCT04988555cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Medical University of South Carolina, Charleston
- McLeod Health, Florence
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。